Pembrolizumab in our country and over the ocean
Prof. MUDr. Jindřich Fínek, Ph.D., MHA
Onkologická a radioterapeutická klinika LF UK a FN Plzeň
Pembrolizumab is a humanized monoclonal antibody against programmed cell death 1 receptors (PD-1) (an IgG4/K isotype with a stabilizing sequence change in the Fc region) produced by recombinant DNA technology in Chinese hamster ovary cells.
pembrolizumab, a humanized monoclonal antibody, programmed cell death 1
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...